Strategic partnership ProThera, Inc. specializes in nutraceuticals for exclusive distribution by healthcare professionals, presenting a clear channel for partnership with clinics, integrative centers, and specialty pharmacies seeking trusted, physician-referred products.

Acquired platform leverage With recent acquisitions and mergers under SFI, Klaire Labs and Complementary Prescriptions capabilities can be cross-sold to existing SFI distributors and professional networks, expanding market reach and portfolio depth.

Product line expansion ProThera’s portfolio including ProThera, Klaire Labs, and Complementary Prescriptions provides opportunities to upsell bundled nutraceuticals across wellness and functional medicine practices, addressing diverse patient needs from probiotics to targeted nutraceuticals.

Mid-market traction Revenue range of ten to twenty-five million with a mid-sized employee base signals potential for scalable partnerships with mid-market wellness distributors and clinics that value personalized account management and reliable supply.

Strategic alliances Recent Puretyclinic partnerships and Klaire Labs association indicate a favorable move toward collaborative channel ecosystems; consider co-marketing, training programs, and exclusive SKUs to deepen doctor and patient adoption.